BIOCORP: Upcoming Investor Meetings
20 September 2021 - 7:30AM
Business Wire
Regulatory News:
BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA PME),
a French company specialized in the design, development, and
manufacturing of innovative medical devices, announces its
participation in the following events:
- SFAF Meeting – September 27, 2021 – 8:30 am– Paris
- Investor Access Event – September 27-28, 2021 - Paris
On these occasions, the Company’s management will highlight the
financial results for the 1st half of 2021, the acceleration of the
partnership strategy and the growth opportunities for its entire
range of connected medical devices.
ABOUT BIOCORP Recognized for its expertise in the development
and manufacture of medical devices and delivery systems, BIOCORP
has today acquired a leading position in the connected medical
device market thanks to Mallya. This smart sensor for insulin
injection pens allows reliable monitoring of injected doses and
thus offers better compliance in the treatment of patients with
diabetes. Available for sale from 2020, Mallya spearheads BIOCORP's
product portfolio of innovative connected solutions. The company
has 70 employees. BIOCORP is listed on Euronext since July 2015
(FR0012788065 – ALCOR). For more information, please visit
www.biocorpsys.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210919005006/en/
CONTACTS BIOCORP Jacques Gardette Chairman of the Board
investisseurs@biocorp.fr
Éric Dessertenne Chief Executive Officer
Sylvaine Dessard Marketing & Communication Director
rp@biocorp.fr + 33 (0)6 88 69 72 85
CONTACTS ULYSSE COMMUNICATION Bruno ARABIAN
barabian@ulysse-communication.com +33 (0)6 87 88 46 26
Nicolas DANIELS ndaniels@ulysse-communication.com +33 (0)6 63 66
59 22
Biocorp (EU:ALCOR)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Biocorp (EU:ALCOR)
Historical Stock Chart
Von Apr 2023 bis Apr 2024